Clinical Outcomes of Remote Training for Advanced Diabetes Technologies During the COVID-19 Pandemic.

Bozzetto, Lutgarda; De Angelis, Raffaele; Calabrese, Ilaria; Giglio, Clemente; Annuzzi, Giovanni

Bozzetto, Lutgarda; De Angelis, Raffaele; Calabrese, Ilaria; Giglio, Clemente; Annuzzi, Giovanni.

Bozzetto L; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
De Angelis R; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Calabrese I; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Giglio C; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
Annuzzi G; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.

J Diabetes Sci Technol ; 16(1): 264-265, 2022 01.

Article in English | MEDLINE | ID: covidwho-1463198

Subject(s)

COVID-19; Diabetes Mellitus, Type 1; Telemedicine; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1/drug therapy; Humans; Hypoglycemic Agents/therapeutic use; Insulin/therapeutic use; Insulin Infusion Systems; Pandemics; SARS-CoV-2

Keywords

Continuous Glucose Monitoring; Continuous Subcutaneous Insulin Infusion; hybrid artificial pancreas; telemedicine; type 1 diabetes

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Telemedicine / Diabetes Mellitus, Type 1 / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Diabetes Sci Technol Journal subject: Endocrinology Year: 2022 Document Type: Article Affiliation country: 19322968211050653

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google